No profile data available.
Onconetix, Inc. (ONCO) is a healthcare company in the healthcare equipment manufacturing contractors industry, based in Cincinnati, United States, with about 5 full-time employees.
It reported revenue of $815,371 for fiscal year 2025, down 67.7% from fiscal year 2024, and net income of -$15.53 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $21,457, down 78.9% from a year before. European Union was its largest region in fiscal year 2025, with 98% of revenue. Its market capitalization was $4.59 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
, a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.
Onconetix reported $815,371 in revenue for fiscal year 2025, down 67.7% from $2.52 million in fiscal year 2024. In Q1 2026 revenue was $21,457.
European Union: 98% of revenue by region in fiscal year 2025, followed by Non-European Union (2%).
$4.59 million as of December 4, 2025.
Listed companies of a similar size in the same industry (healthcare equipment manufacturing contractors) include Precision Optics Corporation, Inc. (POCI), Nortech Systems Incorporated (NSYS), Sintx Technologies, Inc. (SINT), ADM Tronics Unlimited, Inc. (ADMT).